C ognitive impairment and dementia are prevalent after stroke. 1 Given the risks of baseline selection bias, 2, 3 they are probably more common than previously reported. Poststroke cognitive impairment is independently associated with death and disability 4 and institutionalization, 5 and it is important that we identify ways to reduce its occurrence and thus the associated burden of disease. There is a growing awareness that higher physical activity levels are linked to better cognitive function, with compelling data from large epidemiological populations. 6, 7 Intervention trials have added to the weight of evidence: in older adults at risk of cognitive decline, those randomized to a physical activity program had significantly better cognitive outcomes than those randomized to the control group. 8 In the context of stroke, meta-analyses of the research literature indicate that physical activity has a modest but significant positive effect on cognition. 9, 10 It remains a limited research base, however, with <5% of all stroke studies, including a cognitive outcome. 11 AVERT (A Very Early Rehabilitation Trial) was a large randomized controlled trial designed to investigate the efficacy of very early mobilization, compared with usual care, in acute stroke. 12 With its broad inclusion criteria, AVERT is less vulnerable to the baseline selection biases common to much poststroke cognitive research. A corollary of this, however, is the likelihood that many participants had prestroke cognitive impairment; an estimate from meta-analysis of hospital-based studies indicates a prevalence of prestroke dementia of 14%. 1 The effect of early mobilization after stroke on subsequent
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cognitive outcome is unknown. Evidence from the animal literature is encouraging, with a recent study demonstrating that moderate physical activity early after stroke in rats had a positive effect on later cognitive function (8-10 days after the last exercise session). 13 In humans, it may be unrealistic to expect a physical intervention delivered in the first 2 weeks poststroke to have a direct benefit on cognition as measured at 3 months, but indirect benefits of increasing out-of-bed activity during an early, optimally neuroplastic time window are plausible. 14 For example, early poststroke mobilization increases a person's level of consciousness. 15 Improved mental alertness may enhance cognitive processes after stroke, potentially mediating other aspects of recovery through greater engagement in therapy and rehabilitation. Conversely, if there are activityrelated reductions in cerebral blood flow that threaten perfusion of the ischemic penumbra, 16 this may increase the risk of cognitive impairment. It was this uncertainty that led us to include a cognitive outcome measure in AVERT.
Methods

Study Question
AVERT's large data set provides a unique opportunity to explore poststroke cognitive function (the data that support the findings of this study are available from the corresponding author on reasonable request). The central aim of this investigation was to determine, as outlined in AVERT's statistical analysis plan, 17 whether there was a between-group difference in cognitive outcome. We also aimed to quantify the relationships between 3-month cognition and various clinical variables across the full cohort. We hypothesized that baseline markers of cognition-cognitive items from the National Institutes of Health Stroke Scale (NIHSS), 18 Star Cancellation 19 -would be significantly associated with cognition at 3 months. We also predicted that mood disorder and quality of life at 3 months would be significantly associated with 3-month cognition.
Trial Design
AVERT was a pragmatic, parallel-group, single-blind, multicenter, randomized controlled trial with blinded assessment of outcome. It was international, with recruitment sites in Australia, New Zealand, Singapore, Malaysia, and the United Kingdom. The trial had ethical approval from the Human Ethics Committee at each site and was registered with the Australian New Zealand Clinical Trials Registry (https:// www.anzctr.org.au. Unique identifier: ACTRN12606000185561). Informed consent was obtained from all participants or their nominated representative. Details of the study rationale, design, and statistical analysis have been published previously. 17 Eligible participants were aged ≥18 years and were recruited within 24 hours of stroke (first or recurrent, ischemic, or hemorrhagic). Exclusion criteria included premorbid disability, early deterioration, palliation, other serious illness or coronary condition, and falling outside set physiological parameters (blood pressure, heart rate, temperature, oxygen saturation). Participants were randomly assigned to receive usual stroke unit care or very early and more frequent mobilization in addition to usual stroke unit care, stratified by hospital site and stroke severity. The randomization schedule was computer-generated, with allocation concealed and delivered via a secure, purpose-built online interface. The trial ended when the recruitment target was met.
Intervention Delivery
For both intervention and control participants, the components of usual care were at the discretion of individual sites. The very early mobilization intervention was delivered according to a detailed protocol and included 3 crucial elements: (1) begin within 24 hours of stroke onset, (2) focus on out-of-bed activity (eg, sitting, standing, walking), and (3) result in at least 3 additional out-of-bed sessions to usual care. The intervention period lasted 14 days or until discharge from the acute stroke unit, whichever was sooner. Actual treatment dose provided to each group was reported previously 20 and is summarized here. In the intervention group, 92% of patients were mobilized within 24 hours of stroke, compared with 59% in usual care. Median time to first mobilization was 18.5 hours for intervention participants, against 22.4 hours for usual care. During the acute hospital stay, intervention participants were more active than their usual care counterparts: median frequency of out-of-bed activity sessions per day was 6.5 versus 3.0, translating to a median activity duration per day of 31 versus 10 minutes.
Outcome Measures
AVERT's primary outcome was death and disability at 3 months poststroke, measured using the modified Rankin Scale. 21 In 2008 (2 years after recruitment began), the trial management committee approved a protocol revision that added a cognitive measure (Montreal Cognitive Assessment; MoCA 22 ) to the 3-month assessment. The MoCA was recommended in 2006 harmonization standards 23 and subsequently has been confirmed as a valid assessment of cognitive function after stroke. 24, 25 The blinded assessors, who were allied health professionals, were trained in administration and scoring of the MoCA using detailed written instructions (from the MoCA website) and a demonstration video (recorded by Dr Linden, an experienced cognitive neurologist). The MoCA takes ≈10 minutes to complete, is scored out of 30 (with 1 point added for low education; higher scores represent better cognition), and contains sections on visuospatial/executive, naming, memory, attention, language, abstraction, and orientation. We used the original version of the MoCA but modified its format so that the paper case report forms could be machine read using TeleForm (Verity, Inc, Sunnyvale, CA) software. We received faxed portable document format images from sites, and these images were scanned into the software, visually checked, corrected, and stored in the database. As part of our quality assurance process, a single independent researcher (D. Lowe) accessed the portable document format image file for the visuospatial/executive MoCA items and-blind to the original scoring-scored these items. Clear errors in original scoring were corrected. When the 3-month assessment was conducted by telephone, the MoCA was not administered. In participants whose English language fluency led to problems completing the English MoCA, the MoCA version in their primary language was used, and results were transcribed to our case report form. This occurred most frequently at the Singapore and Malaysia sites. For Bahasa Malay, there was no existing MoCA version, so we created and validated one. 26 When the MoCA was not administered, or was incomplete, reasons for the missing data were recorded.
Other relevant outcomes include the NIHSS, 27 a baseline clinical measure of stroke severity. The NIHSS has 4 items relating to cognition, with the NIH Cog-4 (combining the orientation, executive, language, and inattention items) and also the NIH Cog-2 (combining the orientation and language items), yielding useful cognitive information. 18 We administered the Star Cancellation test, a sensitive measure of visual neglect, 19 at baseline. At 3-month follow-up, psychological well-being was evaluated on the Irritability, Depression, and Anxiety scale, 28 which has established validity. 29 Scores on the depression and anxiety subscales range between 0 and 15, with higher scores reflecting greater symptomatology. The Assessment of Quality of Life, 30 which has been validated in stroke, 31 was also administered at 3 months. Scores range between −0.04 and 1, with higher values reflecting a better quality of life.
Statistical Analysis
AVERT's statistical analysis plan was published before trial completion and database lock, and cognitive function at 3 months was a tertiary outcome. 17 Multivariable bootstrapped median regression, including age and NIHSS as covariates, was used to compare MoCA score between the intervention and control groups. Robust linear regression was used to confirm this finding and was run again with pattern mixture models for sensitivity analysis of the unobserved outcomes (missing MoCA data or lost to follow-up). 32 Our a priori approach to missing MoCA data was to define missing because of telephone follow-up as missing-at-random, whereas missing because of other reasons (communication problems related to stroke, unable to use pen/paper, visual problems, refused, other) was classified as missing-not-at-random. Separate regressions were conducted for (1) all participants with complete MoCA data plus those who had died (with these participants assigned a MoCA score of 0), and (2) all surviving participants with complete MoCA data. Prevalence of cognitive impairment is reported at both the originally suggested 25/26 MoCA cutoff 22 and a 23/24 cutoff, identified as more suitable in stroke. 24 Relationships between 3-month MoCA and other clinical variables were examined in the cohort with complete data, using Spearman correlations and bootstrapped median regressions (with age and NIHSS as covariates). Finally, we tested associations between cognitive outcome and both living arrangement and employment status, using multivariable logistic regression (adjusted for age, NIHSS). Analyses were performed using STATA version 14.0.
Results
Missing Data
The participant flowchart is outlined in Figure 1 . Of the total 2104 AVERT participants, 317 (15.1%) had a 3-month assessment that predated introduction of the MoCA, 136 (7.6%) had died before their 3-month assessment, 6 (0.3%) were lost to follow-up, and 456 (25.5%) had completely or partially missing data. Of these 456, 157 (34.4%) had telephone follow-up (missing-at-random). These missing participants were balanced across the intervention (77/751, 10.3%) and usual care (80/737, 10.9%) groups (Fisher exact; P=0.74), and their sex and NIHSS profiles were similar to included participants. However, they were younger (n=157; median, 68. Age and sex profiles were no different to included participants, whereas NIHSS was higher (n=299; median, 9; IQR, 5-15) than in included participants (n=1331; median, 6; IQR, 4-11; Mann-Whitney U test, P<0.001). For analysis, the 1787 who participated after the MoCA's introduction were split into 3 groups (Table 1) : complete MoCA data (n=1189), deaths (n=136), and completely or partially missing data (n=462).
Functional Outcome by Intervention Group
Among the subset with complete MoCA data, there were fewer intervention participants (326/595, 54.8%) than usual care participants (361/594, 60.8%) who had a favorable 3-month functional outcome (modified Rankin Scale score, 0-2). This finding is consistent with the previous report from the full AVERT sample, where fewer people in the intervention group (480/1038, 46.2%) than in usual care (525/1045, 50.2%) had a favorable 3-month outcome. 
Associations Between Cognition and Other Factors in Participants With Complete MoCA Data
Prestroke Vascular Risk Factors
Prior stroke and diabetes mellitus were associated with poorer MoCA outcome (Table 3) . 
Stroke Type
NIH Cog-4, median (IQR) 0 (0-2) 0 (0-2) 3 (1-7) 4 (2-6) 1 (0-3) 1 (0-4) NIH Cog-2, median (IQR) 0 (0-1) 0 (0-1) 1 (0-4) 2 (0-4) 0 (0-2) 0 (0-3
Mood and Quality of Life at 3 Months
Using the depression subscale of the Irritability, Depression, and Anxiety, 34% of participants had borderline depressive symptoms (4-6), with a further 25% having morbid depression (7+). Depression was correlated with poorer cognition (r=−0.15; P<0.001), and this finding was similar when using bootstrapped multivariable median regression (β coefficient, −0.20; 95% CI, −0.32 to −0.09; P<0.001). Using the anxiety subscale, 22% of participants had borderline anxiety 
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symptoms (6) (7) (8) , with a further 11% having morbid anxiety (9+). Anxiety was correlated with poorer cognition (r=−0.13; P<0.001); the finding was similar when using multivariable regression (β coefficient, −0.19; 95% CI, −0.28 to −0.11; P<0.001). Higher quality of life on the Assessment of Quality of Life was correlated with better cognition (r=0.36; P<0.001), a finding that was also evident in regression (β coefficient, 3.76; 95% CI, 2.84 to 4.68; P<0.001; Figure 3 ).
Living Arrangement and Employment
Sixty-one participants (5%) were living in a nursing home or hostel at 3 months. Multivariable logistic regression indicated that lower MoCA score was associated with living in an institution at 3 months (odds ratio, 0.93; 95% CI, 0.89-0.97; P=0.001). In participants who were working before stroke, higher 3-month MoCA score was associated with having returned to work at 3 months (odds ratio, 
Discussion
We did not detect a difference between intervention and control groups in 3-month cognitive outcome. The lack of group difference was present irrespective of whether deaths were assigned a score of zero or were removed from analysis. Cognitive impairment was prevalent in both groups-69% in intervention and 71% in usual care at a MoCA cutoff of 25/26-although lower than the 85% reported previously. 24 At the 23/24 cutoff, prevalence of cognitive impairment was 52% in both groups. This means that, even using a conservative cutoff and restricting the sample to those able to complete the MoCA (milder than the full AVERT cohort), the majority of stroke survivors had difficulties with cognition that could impact their everyday lives. It is intriguing that the AVERT intervention had a negative effect on modified Rankin Scale, but not on MoCA, at 3 months poststroke. The modified Rankin Scale is focussed on functional independence, with an emphasis on walking. Early and more frequent mobilization seems to reduce the capacity for recovery in terms of mobility and functional capacity, without affecting cognition. This pattern of results suggests that the intervention has deleterious effects on physical and motor factors, such as muscle strength, balance, and coordination, but no observable impact on cognitive factors, such as concentration, executive function, and memory.
Given the lack of group difference in cognition, we pooled intervention and control participants together to consider performance on the MoCA subsections. Overall, the profile matched previous reports 33 : naming and orientation items were the best performed, whereas the verbal fluency and delayed recall items were the most difficult. This pooled cohort was also used to investigate associates of cognitive function. The finding of a relationship between poorer cognition and previous stroke (either symptomatic or identified on imaging) has precedent. Recurrent stroke has been strongly associated with the likelihood of dementia. 1 The link to diabetes mellitus has also been demonstrated previously, with diabetes mellitus independently associated with cognitive impairment in ischemic stroke survivors. 35 We identified significant correlations between 3-month MoCA and baseline cognition, as reflected by the NIH Cog-4 and Cog-2 scores. Thus, our previous indirect evidence that the cognition-related NIHSS items are meaningful indicators of cognitive function in large groups 18 gained more direct support. Although the link between cognitive impairment and depression is well established in the general population, it has not been widely investigated in stroke. In 1 previous study of 106 ischemic stroke survivors that included neuropsychological testing and a psychiatric diagnosis, the investigators found an association between depression and cognition, particularly in the domains of memory, nonverbal problem solving, and attention. 36 Our data revealed significant negative associations between cognition and both depression and anxiety, but the correlations were weak (r<0.20). A moderate positive association was found between cognition and quality of life, confirming our previous finding from a smaller sample. 37 There are multiple threads that can help explain the negative effects of cognitive deficits on quality of life. Our results indicate that participants with poorer cognitive function were more likely to be living in an institution, matching an earlier finding. 5 We know stroke survivors with cognitive impairment are more dependent on personal assistance for everyday activities, with costs of care having major resource implications for the broader society. 38 In the group who were working before stroke, those with better 3-month cognitive function were significantly more likely to have returned to work.
A limitation of this work is the nonrandom nature of the missing MoCA data. As a result of broad inclusion criteria and multiple recruitment sites across the world, the full AVERT cohort was typical of the inpatient stroke population, and thus the primary outcome findings have wide generalisability. The same is not true of the AVERT subsample with 3-month cognitive results. Although some data were missingat-random (assessed before the MoCA's introduction to the trial, telephone follow-up), other data were not (incomplete MoCA data, deaths). The research literature on poststroke cognition is beset by structural selection biases that result in samples that are atypically mild in terms of neurological, linguistic, and cognitive deficits. 2, 3 Most cognitive assessments, the MoCA included, are strongly reliant on both receptive and expressive language skills, and stroke survivors with aphasia or with a non-English speaking background are more likely to have missing data. These biases are unlikely to have affected the group comparison, but do impact on overall cognitive outcomes. The addition of a point for people with ≤12 years of education was the blunt but clinically pragmatic suggestion built into the original MoCA 22 ; our data indicate that this additional point was insufficient to fully adjust for the effect of education. Finally, a full neuropsychological evaluation would have provided a more sensitive measure of cognitive impairment than the MoCA. This was not feasible in the AVERT context, given the already lengthy clinical assessments and detailed health economic evaluation at 3-month follow-up.
AVERT is the largest stroke rehabilitation trial ever conducted, and complete cognitive data were available at 3 months poststroke for 1189 participants. Results indicate that exposure to early and more frequent mobilization after stroke did not affect cognitive outcome.
